The Sarpogrelate Hydrochloride Market is projected to grow from USD 128.6 million in 2026 to USD 179.3 million by 2034, registering a 4.2% CAGR. Growth is driven by rising cardiovascular and peripheral arterial disease cases, aging populations, and demand for safer antiplatelet therapies.
Full Report
https://www.24chemicalresearch.....com/reports/305285/